Annual FCF
-$74.93 M
-$58.50 M-356.13%
31 December 2023
Summary:
Apogee Therapeutics annual free cash flow is currently -$74.93 million, with the most recent change of -$58.50 million (-356.13%) on 31 December 2023. APGE annual FCF is now -356.13% below its all-time high of -$16.43 million, reached on 31 December 2022.APGE Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$43.27 M
-$13.92 M-47.44%
30 September 2024
Summary:
Apogee Therapeutics quarterly free cash flow is currently -$43.27 million, with the most recent change of -$13.92 million (-47.44%) on 30 September 2024. Over the past year, it has dropped by -$23.39 million (-117.68%). APGE quarterly FCF is now -309.92% below its all-time high of -$10.56 million, reached on 31 March 2023.APGE Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$134.37 M
-$23.39 M-21.08%
30 September 2024
Summary:
Apogee Therapeutics TTM free cash flow is currently -$134.37 million, with the most recent change of -$23.39 million (-21.08%) on 30 September 2024. Over the past year, it has dropped by -$89.36 million (-198.55%). APGE TTM FCF is now -1172.78% below its all-time high of -$10.56 million, reached on 31 March 2023.APGE TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APGE Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -356.1% | -117.7% | -198.6% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
APGE Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -356.1% | at low | -309.9% | at low | -1172.8% | at low |
| 5 y | 5 years | -356.1% | at low | -309.9% | at low | -1172.8% | at low |
| alltime | all time | -356.1% | at low | -309.9% | at low | -1172.8% | at low |
Apogee Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$43.27 M(+47.4%) | -$134.37 M(+21.1%) |
| June 2024 | - | -$29.35 M(-8.2%) | -$110.97 M(+15.4%) |
| Mar 2024 | - | -$31.99 M(+7.5%) | -$96.19 M(+28.7%) |
| Dec 2023 | -$74.93 M | -$29.75 M(+49.7%) | -$74.76 M(+66.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$19.88 M(+36.4%) | -$45.01 M(+79.1%) |
| June 2023 | - | -$14.57 M(+38.0%) | -$25.13 M(+138.0%) |
| Mar 2023 | - | -$10.56 M | -$10.56 M |
| Dec 2022 | -$16.43 M | - | - |
FAQ
- What is Apogee Therapeutics annual free cash flow?
- What is the all time high annual FCF for Apogee Therapeutics?
- What is Apogee Therapeutics annual FCF year-on-year change?
- What is Apogee Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Apogee Therapeutics?
- What is Apogee Therapeutics quarterly FCF year-on-year change?
- What is Apogee Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Apogee Therapeutics?
- What is Apogee Therapeutics TTM FCF year-on-year change?
What is Apogee Therapeutics annual free cash flow?
The current annual FCF of APGE is -$74.93 M
What is the all time high annual FCF for Apogee Therapeutics?
Apogee Therapeutics all-time high annual free cash flow is -$16.43 M
What is Apogee Therapeutics annual FCF year-on-year change?
Over the past year, APGE annual free cash flow has changed by -$58.50 M (-356.13%)
What is Apogee Therapeutics quarterly free cash flow?
The current quarterly FCF of APGE is -$43.27 M
What is the all time high quarterly FCF for Apogee Therapeutics?
Apogee Therapeutics all-time high quarterly free cash flow is -$10.56 M
What is Apogee Therapeutics quarterly FCF year-on-year change?
Over the past year, APGE quarterly free cash flow has changed by -$23.39 M (-117.68%)
What is Apogee Therapeutics TTM free cash flow?
The current TTM FCF of APGE is -$134.37 M
What is the all time high TTM FCF for Apogee Therapeutics?
Apogee Therapeutics all-time high TTM free cash flow is -$10.56 M
What is Apogee Therapeutics TTM FCF year-on-year change?
Over the past year, APGE TTM free cash flow has changed by -$89.36 M (-198.55%)